Mechanisms regulating the recruitment of macrophages into hypoxic areas of tumors and other ischemic tissues

被引:696
作者
Murdoch, C [1 ]
Giannoudis, A [1 ]
Lewis, CE [1 ]
机构
[1] Univ Sheffield, Sch Med, Acad Unit Pathol, Div Genom Med,Tumor Targeting Grp, Sheffield S10 2RX, S Yorkshire, England
关键词
D O I
10.1182/blood-2004-03-1109
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
The mechanisms responsible for recruiting monocytes from the bloodstream into solid tumors are now well characterized. However, recent evidence has shown that these cells then differentiate into macrophages and accumulate in large numbers in avascular and necrotic areas where they are exposed to hypoxia. This parallels their tendency to congregate in ischemic areas of other diseased tissues such as atherosclerotic plaques and arthritic joints. In tumors, macrophages appear to undergo marked phenotypic changes when exposed to hypoxia and to switch on their expression of a number of mitogenic and proangiogenic cytokines and enzymes. This then promotes tumor growth, angiogenesis, and metastasis. Here, we compare the various mechanisms responsible for monocyte recruitment into tumors with those regulating the accumulation of macrophages in hypoxic/necrotic areas. Because the latter are best characterized in human tumors, we focus mainly on these but also discuss their relevance to macrophage migration in ischemic areas of other diseased tissues. Finally, we discuss the relevance of these mechanisms to the development of novel cancer therapies, both in providing targets to reduce the proangiogenic contribution made by hypoxic macrophages in tumors and in developing the use of macrophages to deliver therapeutic gene constructs to hypoxic areas of diseased tissues. (C) 2004 by The American Society of Hematology.
引用
收藏
页码:2224 / 2234
页数:11
相关论文
共 180 条
  • [1] Monocyte chemotactic protein-1 in proliferative vitreoretinal disorders
    AbuElAsrar, AM
    VanDamme, J
    Put, W
    Veckeneer, M
    Dralands, L
    Billiau, A
    Missotten, L
    [J]. AMERICAN JOURNAL OF OPHTHALMOLOGY, 1997, 123 (05) : 599 - 606
  • [2] Adams J, 2000, CANCER RES, V60, P2898
  • [3] Afuwape AO, 2002, HISTOL HISTOPATHOL, V17, P961, DOI 10.14670/HH-17.961
  • [4] Macrophage infiltration in human non-small-cell lung cancer: the role of CC chemokines
    Arenberg, DA
    Keane, MP
    DiGiovine, B
    Kunkel, SL
    Strom, SRB
    Burdick, MD
    Iannettoni, MD
    Strieter, RM
    [J]. CANCER IMMUNOLOGY IMMUNOTHERAPY, 2000, 49 (02) : 63 - 70
  • [5] Ashida N, 2001, ANN NY ACAD SCI, V947, P387
  • [6] Azenshtein E, 2002, CANCER RES, V62, P1093
  • [7] Up-regulation of macrophage migration inhibitory factor gene and protein expression in glial tumor cells during hypoxic and hypoglycemic stress indicates a critical role for angiogenesis in glioblastoma multiforme
    Bacher, M
    Schrader, J
    Thompson, N
    Kuschela, K
    Gemsa, D
    Waeber, G
    Schlegel, J
    [J]. AMERICAN JOURNAL OF PATHOLOGY, 2003, 162 (01) : 11 - 17
  • [8] Chemokine biology in cancer
    Balkwill, F
    [J]. SEMINARS IN IMMUNOLOGY, 2003, 15 (01) : 49 - 55
  • [9] Genes commonly upregulated by hypoxia in human breast cancer cells MCF-7 and MDA-MB-231
    Bando, H
    Toi, M
    Kitada, K
    Koike, M
    [J]. BIOMEDICINE & PHARMACOTHERAPY, 2003, 57 (08) : 333 - 340
  • [10] Migration of human monocytes in response to vascular endothelial growth factor (VEGF) is mediated via the VEGF receptor flt-1
    Barleon, B
    Sozzani, S
    Zhou, D
    Weich, HA
    Mantovani, A
    Marme, D
    [J]. BLOOD, 1996, 87 (08) : 3336 - 3343